Status:
RECRUITING
EUS-guided Celiac Plexus Block vs. Sham in Chronic Pancreatitis
Lead Sponsor:
Orlando Health, Inc.
Conditions:
Chronic Pancreatitis
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The aim of this randomized trial is to assess the efficacy of EUS-CPB in the alleviation of abdominal pain in patients with chronic pancreatitis.
Detailed Description
Chronic pancreatitis is a complex fibroinflammatory disease arising from numerous etiological factors and a variety of clinical manifestations. Abdominal pain is the most debilitating complication and...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Abdominal pain of at least 3 months duration and a VAS score ≥ 3, with or without the use of narcotic analgesics.
- Diagnosis of chronic pancreatitis on EUS examination, with ≥ 5 features on EUS.
- No other cause of abdominal pain
Exclusion
- Age \< 18 years.
- History of prior EUS-CPB.
- Use of anticoagulants that cannot be discontinued for the procedure.
- Clinically significant allergy to bupivacaine or triamcinolone.
- Unable to obtain consent for the procedure from either the patient or LAR.
- Intrauterine pregnancy.
Key Trial Info
Start Date :
December 7 2023
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 31 2026
Estimated Enrollment :
94 Patients enrolled
Trial Details
Trial ID
NCT06178315
Start Date
December 7 2023
End Date
December 31 2026
Last Update
December 21 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Orlando Health
Orlando, Florida, United States, 32806